omega-n-methylarginine has been researched along with Diabetic Neuropathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SR; Pan, HL | 1 |
1 other study(ies) available for omega-n-methylarginine and Diabetic Neuropathies
Article | Year |
---|---|
Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Enzyme Inhibitors; Injections, Spinal; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley | 2003 |